₹508.40
−0.01%NSE close, 16 Nov 2026
−28.14%
Amrutanjan Health Care is a small cap company, listed on NSE under the symbol AMRUTANJAN. At ₹508.40 a share, the market values the whole company at ₹1,470 crore.
In FY26, it reported sales of ₹503 crore and a net profit of ₹58 crore, an operating margin of 15.1%. Over the last three years, sales grew 9.8% a year and net profit grew 13.3% a year.
The market values the company at 25.7 times its profit over the last twelve months and 3.83 times its book value; its return on equity is 14.9% and it has almost no borrowings.
Promoters hold 46.52% of the shares. Foreign institutions hold 3.47%, and domestic institutions, mutual funds among them, 6.90%.
Over the past year the share price has fallen 28.2%, and it is 31.7% below its 52-week high.
₹ crore. Standalone figures: the company files no consolidated results.
Record date for the purpose of Dividend is 07-Nov-2026.
Board of Directors at its meeting held on November 03, 2026, declared Interim Dividend of Re. 1 per equity share.
The financial results for the period ended September 30, 2026.
| Dec 2025 |
|---|
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 117 | 127 | 83.7 | 110 | 123 | 135 | 94.1 | 118 | 141 | 150 | 103 | 135 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 95.4 | 111 | 80.2 | 96.3 | 99.4 | 118 | 85.6 | 101 | 116 | 124 | 96.7 | 112 |
| Operating profit | 21.6 | 15.6 | 3.6 | 13.6 | 23.4 | 17.7 | 8.5 | 16.5 | 25.2 | 25.5 | 6.2 | 23.6 |
| Operating margin | 18.4% | 12.3% | 4.2% | 12.4% | 19.0% | 13.1% | 9.0% | 14.0% | 17.8% | 17.1% | 6.1% | 17.5% |
| Other income | 3.8 | 5.5 | 4.5 | 4.1 | 4.4 | 4.8 | 4.4 | 4.3 | 4.1 | 4.7 | 3.8 | 3.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Depreciation | 1.6 | 1.5 | 1.6 | 1.7 | 1.7 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | 1.9 | 3.5 |
| Profit before tax | 23.7 | 19.6 | 6.4 | 15.9 | 26.0 | 20.9 | 11.3 | 19.2 | 26.4 | 21.0 | 6.1 | 23.1 |
| Tax | 6.3 | 6.0 | 1.7 | 4.1 | 6.7 | 5.7 | 3.0 | 5.3 | 6.9 | 4.8 | 1.7 | 5.8 |
| Net profit | 17.5 | 13.7 | 4.6 | 11.8 | 19.3 | 15.2 | 8.3 | 14.0 | 19.5 | 16.2 | 4.4 | 17.3 |
| EPS (₹) | 6.05 | 4.72 | 1.60 | 4.08 | 6.66 | 5.25 | 2.87 | 4.83 | 6.73 | 5.60 | 1.51 | 5.98 |
₹ crore, financial years to March.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Sales | 253 | 261 | 333 | 406 | 380 | 421 | 452 | 503 |
| Expenses | 222 | 231 | 258 | 326 | 335 | 370 | 394 | 427 |
| Operating profit | 31.3 | 30.7 | 74.8 | 79.5 | 44.4 | 51.2 | 58.2 | 75.7 |
| Operating margin | 12.4% | 11.7% | 22.5% | 19.6% | 11.7% | 12.2% | 12.9% | 15.1% |
| Other income | 7.1 | 8.3 | 11.3 | 15.4 | 14.5 | 16.9 | 17.7 | 17.6 |
| Interest | 0.1 | 0.2 | 0.5 | 0.5 | 0.1 | 0.2 | 0.2 | 0.2 |
| Depreciation | 3.2 | 4.4 | 3.7 | 3.8 | 5.2 | 6.1 | 6.5 | 6.3 |
| Profit before tax | 35.2 | 34.5 | 81.9 | 90.6 | 53.6 | 62.0 | 69.1 | 77.9 |
| Tax | 10.2 | 9.4 | 20.7 | 23.4 | 13.8 | 17.0 | 18.3 | 20.0 |
| Net profit | 24.5 | 25.1 | 61.2 | 67.2 | 39.8 | 45.0 | 50.8 | 57.9 |
| EPS (₹) | 8.38 | 8.58 | 20.94 | 23.05 | 13.64 | 15.53 | 17.58 | 20.03 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 53.2 | 50.9 | 36.0 | −2.1 |
| From investing | −36.2 | −31.0 | −21.2 | 7.4 |
| From financing | −17.7 | −13.5 | −13.6 | −8.6 |
| Spent on fixed assets | −23.5 | −35.6 | −55.0 | −36.5 |
| Free cash flow | 29.7 | 15.4 | −19.0 | −38.6 |
Margins, returns, debt, tax and cash.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Net margin | 9.7% | 9.6% | 18.4% | 16.6% | 10.5% | 10.7% | 11.3% | 11.5% |
| Operating margin | 12.4% | 11.7% | 22.5% | 19.6% | 11.7% | 12.2% | 12.9% | 15.1% |
| Return on equity | – | – | – | – | 13.7% | 15.6% | 15.6% | 15.6% |
| Return on capital employed | – | – | – | – | 18.5% | 21.5% | 21.2% | 21.1% |
| Return on assets | – | – | – | – | 11.0% | 12.3% | 12.1% | 11.4% |
| Debt to equity | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest coverage | 440.60 | 157.60 | 164.80 | 189.70 | 671.50 | 414.00 | 315.20 | 390.50 |
| Debt to assets | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 |
| Current ratio | – | – | – | – | 4.12 | 4.23 | 3.44 | 2.31 |
| Quick ratio | – | – | – | – | 3.66 | 3.82 | 3.11 | 2.02 |
| Cash ratio | – | – | – | – | 0.08 | 0.05 | 0.12 | 0.09 |
| Asset turnover | – | – | – | – | 1.05 | 1.15 | 1.07 | 0.99 |
| Fixed asset turnover | – | – | – | – | 8.18 | 8.92 | 9.47 | 10.09 |
| Inventory turnover | – | – | – | – | – | 7.30 | 8.20 | 6.50 |
| Receivables turnover | – | – | – | – | 11.50 | 8.80 | 8.10 | 8.30 |
| Gross margin | – | – | – | – | – | 49.7% | 50.6% | 51.4% |
| Cash from operations to profit | – | – | – | 79.0% | – | – | 100.0% | 62.0% |
| Effective tax rate | 28.9% | 27.2% | 25.3% | 25.8% | 25.8% | 27.4% | 26.5% | 25.6% |
ESG RATINGS
A copy Srutinizers report of Annual General Meeting held on September 23, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on September 23, 2026
BRSR for the FY 2025-26
Notice of Annual General Meeting to be held on September 23, 2026
Record date for the purpose of Dividend & Meeting is 11-Sep-2026.
The financial results for the period ended Jun 30, 2026.